Announcements Trials

Browse Landscape

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 15 Papillomavirus Infections 9 Uterine Cervical Neoplasms 7 Pancreatic Neoplasms 6 Breast Neoplasms 6 Ovarian Neoplasms 5 Prostatic Neoplasms 4 Neuroendocrine Tumors 4 Neoplasm Metastasis 4 Myasthenia Gravis 3 Multiple Myeloma 3 Melanoma 3 Lymphoma 3 Lung Neoplasms 3 Autoimmune Diseases 3 Thyroid Diseases 2 Pancreatic Cyst 2 Neuroblastoma 2 Mesothelioma, Malignant 2 Lymphoma, Non-Hodgkin 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Hairy Cell 2 Leukemia 2 Hematologic Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 COVID-19 2 Brain Neoplasms 2 Abortion, Spontaneous 2

Interventions

Ipilimumab 29 Nivolumab 23 pembrolizumab 14 incomplete Freund's adjuvant 10 Cyclophosphamide 10 Melphalan 9 Interleukin-2 9 CTLA-4 Antigen 8 tebentafusp 7 sargramostim 7 Temozolomide 7 MART-1 Antigen 7 Dacarbazine 7 Ranibizumab 6 montanide ISA 51 5 fludarabine phosphate 5 fludarabine 5 Sunitinib 5 Radiosurgery 5 Carboplatin 5 Blood Specimen Collection 5 Bevacizumab 5 aldesleukin 4 aflibercept 4 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Biopsy 4 trametinib 3 sotrastaurin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Uveal Melanoma × Data Collection × Clear all

NCT06432660 2026-02-06

PROMPT

Duke University

Active not recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡